Editors

Editor-in-Chief:

Eric K Rowinsky, MD
Insprina, Inc., United States

Founding Editor & Associate Editor: Daniel Von Hoff, Tucson, AZ, USA

Associate Editors:
Todd Fehniger, MD, PhD, Washington University, United States
David Hong, MD, Anderson Cancer Center, The University of Texas, United States
Razelle Kurzrock, MD, Moores Cancer Center, University of California San Diego, United States
Eric Raymond, MD, PhD, Hospital Paris Saint-Joseph, France
Gary K Schwartz, MD, PhD, Columbia MR Research Center, Columbia University in the City of New York, United States

Editorial Advisory Board:
Julie R Brahmer, MD, Johns Hopkins University School of Medicine, United States
Emiliano Calvo, MD, START Madrid, Spain
Richard D Carvajal, MD, Northwell Health Cancer Institute, Monter Cancer Center, United States
Samuel R Denmeade, MD, Johns Hopkins University School of Medicine, United States
Antoine Italiano, PhD, Bordeaux Institute of Oncology, University of Bordeaux, France
Ning Li, MD, Chinese Academy of Medical College & Peking Union Medical College, China
Patricia M LoRusso, DO, PHD (HC), FAACR, Yale Cancer Center, Yale University, United States
Christophe Massard, MD, PhD, Therapeutic Innovation and Early Trials Department (DITEP), Gustave Roussy, France
Gary W Middleton, MB, BS, MD, FRCP, Institute of Immunology and Immunotherapy, University of Birmingham, United Kingdom
Alain Mita, MD, Cedars-Sinai Medical Center, United States
Monica Mita, MD, Cedars-Sinai Medical Center, United States
Sun Young Rha, PhD, Cancer Metastasis Research Center, Yonsei University College of Medicine, Korea
Manish Sharma, MD, START Midwest, United States
Anil K Sood, MD, Anderson Cancer Center, The University of Texas, United States
Alex Sparreboom, PhD, Outcomes and Translational Sciences Affiliated Faculty, Ohio State University, United States
Josep Tabernero, MD, PhD, Vall d'Hebron University Hospital and Vall d'Hebron Institute, Spain
Timothy Yap, MD, University of Texas MD Anderson Cancer Center, United States